ОБ ЭТОМ ЭПИЗОДЕ

английский
США

РАСШИФРОВКА 🔗

ПОИСК ПРОШЛЫХ ЭПИЗОДОВ

Искать прошлые эпизоды NeuroFrontiers.

ДРУГИЕ ЭПИЗОДЫ В ЭТОМ ПОДКАсте

Host: Brian P. McDonough, MD, FAAFP Guest: Austin Larson, MD Emerging research on thymidine kinase 2 deficiency (TK2d) provides new insights into its global genetic prevalence and variability across genetic ancestries. By combining clinical literature with large genomic databases, in…
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC The role of cell-based therapies in multiple sclerosis (MS) is evolving, with immune system replacement via autologous stem cells, investigational mesenchymal repair strategies, and CAR T-cell approaches changing the treatment …
Guest: Henry Kaminski, MD Myasthenia gravis is an unpredictable condition, with symptoms and treatment responses that can vary widely from one patient to the next. Tune in to hear Dr. Henry Kaminski explain how to navigate this variability and make thoughtful, individualized treatment de…
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC Cxplore how cell-based therapies are reshaping treatment strategies for multiple sclerosis (MS). Hear from Dr. Mark Freedman as he examines the scientific rationale behind emerging strategies. Dr. Freedman is a Profes…
Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из ReachMD, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.